Product Information
VILAZODONE HCL 40 MG TABLET is a generic product labeled by Apotex Corp., priced at $1.1992 per EA under NDC 60505477403. Its NADAC has been published 177 times since Oct 5, 2022.
FDA first approved this application on Jan 21, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Apotex Corp.NDC
60505477403
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
VILAZODONE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022567FDA Approved
1/21/2011
TE Code
AB
On Market Since
6/4/2022
Price Statistics
The NADAC for VILAZODONE HCL 40 MG TABLET has been published 177 times since Oct 5, 2022, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1992 per EA |
|---|---|
| All-time high | $1.7828 (Nov 16, 2022) |
| All-time low | $0.8616 (Jul 17, 2024) |
| 52-week high | $1.2319 |
| 52-week low | $1.0739 |
| Median price | $1.2168 |
| Average price | $1.2824 |
| Largest weekly change | -29.2% (Jul 17, 2024) |
| Weeks tracked | 177 |
| Tracking since | Oct 5, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+11.7%
3Y
-19.9%
5Y
N/A
All
-19.6%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vilazodone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VILAZODONE HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VILAZODONE HCL 40 MG TABLET, manufactured by Apotex Corp., is $1.1992 per EA (NDC 60505477403), effective Feb 18, 2026.
How has the price of VILAZODONE HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for VILAZODONE HCL 40 MG TABLET has declined 19.6%. It has been tracked across 177 weekly CMS publications since Oct 5, 2022.
What are the highest and lowest recorded NADAC prices for VILAZODONE HCL 40 MG TABLET?
Since Oct 5, 2022, the NADAC for VILAZODONE HCL 40 MG TABLET has ranged from a low of $0.8616 (Jul 17, 2024) to a high of $1.7828 (Nov 16, 2022), with a median of $1.2168 per EA.
Are there cheaper alternatives to VILAZODONE HCL 40 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VILAZODONE HCL 40 MG TABLET, is $0.8400 per EA — about 30% below VILAZODONE HCL 40 MG TABLET.
Who manufactures VILAZODONE HCL 40 MG TABLET?
VILAZODONE HCL 40 MG TABLET (NDC 60505477403) is labeled by Apotex Corp., and CMS classifies it as a generic product.